Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion type Assertion NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_head.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion wasGeneratedBy ECO_0000203 NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_provenance.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion wasDerivedFrom befree-20140225 NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_provenance.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion SIO_000772 18536571 NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_provenance.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion evidence source_evidence_literature NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_provenance.
- NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_assertion description "[One possible pathomechanism causing leukemia is that clones of cells harboring acquired CSF3R mutations have a growth advantage over wild type cells in vivo during granulocyte-colony stimulating factor treatment due to activation of STAT5 and ss-catenin, both known to be involved in leukemogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212880.RAo5zlafZFoMAMKEWE0WSAe7Cz7JH4XPsz3vgigIrmYCQ130_provenance.